[1]
S. V. Jargin, “Management of Type 2 Diabetes Mellitus with Overweight: Focus on SGLT-2 Inhibitors and GLP-1 Receptor Agonists”, Eur J Ther, vol. 25, no. 2, pp. 93–96, Apr. 2023.